PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7418971-2	1980	Reduction in tumour load 4 hr after the administration of cycloheximide and CCl4 is life-saving: treatment with a hepatotoxic dose of CCl4 30 hr before challenge with cycloheximide and CCl4 also nullifies that otherwise life-threatening treatment.	Cycloheximide	58-71	chemokine (C-C motif) ligand 4	Mus musculus	134-138	
4043313-1	1985	The fatal syndrome produced by cycloheximide given 6 h after a hepatonecrogenic dose of CCl4 is due neither to direct toxic synergism between CCl4 and cycloheximide nor to transient sinusoidal thrombosis.	Cycloheximide	31-44	chemokine (C-C motif) ligand 4	Mus musculus	88-92	
4043313-1	1985	The fatal syndrome produced by cycloheximide given 6 h after a hepatonecrogenic dose of CCl4 is due neither to direct toxic synergism between CCl4 and cycloheximide nor to transient sinusoidal thrombosis.	Cycloheximide	31-44	chemokine (C-C motif) ligand 4	Mus musculus	142-146	
6512024-1	1984	When a hepatotoxic dose of CCl4 is followed in 6 h (but not in 18 h) by 30 micrograms per g body weight of cycloheximide, a lethal, shock-like state develops.	Cycloheximide	107-120	chemokine (C-C motif) ligand 4	Mus musculus	27-31	
7418971-2	1980	Reduction in tumour load 4 hr after the administration of cycloheximide and CCl4 is life-saving: treatment with a hepatotoxic dose of CCl4 30 hr before challenge with cycloheximide and CCl4 also nullifies that otherwise life-threatening treatment.	Cycloheximide	58-71	chemokine (C-C motif) ligand 4	Mus musculus	134-138	
7418971-2	1980	Reduction in tumour load 4 hr after the administration of cycloheximide and CCl4 is life-saving: treatment with a hepatotoxic dose of CCl4 30 hr before challenge with cycloheximide and CCl4 also nullifies that otherwise life-threatening treatment.	Cycloheximide	167-180	chemokine (C-C motif) ligand 4	Mus musculus	134-138	
7418971-2	1980	Reduction in tumour load 4 hr after the administration of cycloheximide and CCl4 is life-saving: treatment with a hepatotoxic dose of CCl4 30 hr before challenge with cycloheximide and CCl4 also nullifies that otherwise life-threatening treatment.	Cycloheximide	167-180	chemokine (C-C motif) ligand 4	Mus musculus	134-138	
7835696-1	1995	The murine macrophage inflammatory protein 1 beta mRNA (MIP-1 beta) is rapidly and transiently induced in macrophages by lipopolysaccharide (LPS), serum or cycloheximide.	Cycloheximide	156-169	chemokine (C-C motif) ligand 4	Mus musculus	11-49	
7835696-1	1995	The murine macrophage inflammatory protein 1 beta mRNA (MIP-1 beta) is rapidly and transiently induced in macrophages by lipopolysaccharide (LPS), serum or cycloheximide.	Cycloheximide	156-169	chemokine (C-C motif) ligand 4	Mus musculus	56-66